A pharmaceutical company preparing an electronic Common Tech…
A pharmaceutical company preparing an electronic Common Technical Document (eCTD) submission for a regulatory authority identifies several technical deficiencies during final quality control review, including unreadable scanned documents, non-functional internal hyperlinks, restricted file access settings, and inconsistencies in document structure and navigation.Discuss the potential regulatory, technical validation, and operational consequences these deficiencies may have on the acceptance, review efficiency, and overall assessment of the submission if not corrected before submission.
Read Details